Lv3
380 积分 2023-11-27 加入
[Current status and challenges of clinical research and development of new drugs for liver diseases]
13天前
已完结
[Current status and challenges of clinical research and development of new drugs for liver diseases]
13天前
已关闭
MafG/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells
4个月前
已完结
Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review
5个月前
已完结
Hesperetin derivative decreases CCl4‐induced hepatic fibrosis by Ptch1‐dependent mechanisms
9个月前
已完结
Discovery and development of benzene sulfonamide derivatives as anti-hepatic fibrosis agents
9个月前
已完结
Rational design, synthesis and activities of phenanthrene derivatives against hepatic fibrosis
9个月前
已完结
Rational design, synthesis and activities of phenanthrene derivatives against hepatic fibrosis
9个月前
已完结
Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis
9个月前
已完结
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins
10个月前
已关闭
皖公网安备34019202002308
